SIGA Technologies, Inc. (SIGA)
NASDAQ: SIGA · Real-Time Price · USD
6.25
-0.01 (-0.16%)
At close: Nov 20, 2024, 4:00 PM
6.23
-0.02 (-0.32%)
Pre-market: Nov 21, 2024, 5:40 AM EST
SIGA Technologies Revenue
SIGA Technologies had revenue of $10.01M in the quarter ending September 30, 2024, with 8.39% growth. This brings the company's revenue in the last twelve months to $173.73M, up 399.31% year-over-year. In the year 2023, SIGA Technologies had annual revenue of $139.92M with 26.31% growth.
Revenue (ttm)
$173.73M
Revenue Growth
+399.31%
P/S Ratio
2.56
Revenue / Employee
$3,860,697
Employees
45
Market Cap
446.28M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 139.92M | 29.14M | 26.31% |
Dec 31, 2022 | 110.78M | -22.89M | -17.13% |
Dec 31, 2021 | 133.67M | 8.71M | 6.97% |
Dec 31, 2020 | 124.96M | 98.22M | 367.28% |
Dec 31, 2019 | 26.74M | -450.31M | -94.39% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Health Catalyst | 302.06M |
Xeris Biopharma Holdings | 187.36M |
Pacific Biosciences of California | 173.15M |
Arcturus Therapeutics Holdings | 160.40M |
National Research | 144.16M |
Zevra Therapeutics | 24.49M |
OmniAb | 20.41M |
Allogene Therapeutics | 43.00K |
SIGA News
- 13 days ago - SIGA Technologies (SIGA) Shares Tumble After Mpox Therapy Fails, Chief Medical Officer Terminated - Hagens Berman - GlobeNewsWire
- 13 days ago - SIGA Technologies, Inc. (SIGA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 21 days ago - SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial Results - GlobeNewsWire
- 4 weeks ago - Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating SIGA Technologies, Inc. for potential violations of federal securities laws - PRNewsWire
- 4 weeks ago - SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies - GlobeNewsWire
- 6 weeks ago - Siga Technologies to supply mpox therapy in Morocco - Reuters
- 6 weeks ago - SIGA Announces Agreement to Supply TPOXX® in Morocco - GlobeNewsWire
- 6 weeks ago - Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors - Business Wire